Currently, there are 216.70M common shares owned by the public and among those 216.15M shares have been available to trade.
The company’s stock has a 5-day price change of 0.74% and -25.76% over the past three months. NEOG shares are trading -39.23% year to date (YTD), with the 12-month market performance down to -40.77% lower. It has a 12-month low price of $11.46 and touched a high of $20.81 over the same period. NEOG has an average intraday trading volume of 1.72 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.37%, -12.47%, and -17.85% respectively.
Institutional ownership of Neogen Corp (NASDAQ: NEOG) shares accounts for 117.84% of the company’s 216.70M shares outstanding.
It has a market capitalization of $2.65B and a beta (3y monthly) value of 1.23. The earnings-per-share (ttm) stands at -$0.11. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.85% over the week and 4.62% over the month.
Analysts forecast that Neogen Corp (NEOG) will achieve an EPS of 0.1 for the current quarter, 0.14 for the next quarter and 0.54 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.1 while analysts give the company a high EPS estimate of 0.1. Comparatively, EPS for the current quarter was 0.11 a year ago. Earnings per share for the fiscal year are expected to increase by 31.25%, and 400.00% over the next financial year.
Looking at the support for the NEOG, a number of firms have released research notes about the stock. Guggenheim stated their Buy rating for the stock in a research note on December 19, 2024, with the firm’s price target at $15. Wells Fargo coverage for the Neogen Corp (NEOG) stock in a research note released on June 16, 2023 offered a Overweight rating with a price target of $22. William Blair was of a view on November 22, 2022 that the stock is Outperform, while Piper Sandler gave the stock Neutral rating on July 12, 2022, issuing a price target of $25. Guggenheim on their part issued Neutral rating on May 23, 2019.
